financetom
Business
financetom
/
Business
/
Supernus Pharmaceuticals Insider Sold Shares Worth $391,568, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Supernus Pharmaceuticals Insider Sold Shares Worth $391,568, According to a Recent SEC Filing
Nov 12, 2024 9:23 PM

04:28 PM EST, 11/12/2024 (MT Newswires) -- Georges Gemayel, Director, on November 08, 2024, sold 10,787 shares in Supernus Pharmaceuticals ( SUPN ) for $391,568. Following the Form 4 filing with the SEC, Gemayel has control over a total of 13,315 shares of the company, with 13,315 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1356576/000162828024047145/xslF345X05/wk-form4_1731445977.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Largo Down More Than 50% In US Premarket As Announces Pricing of Registered Direct Offering and Private Placement, Reliance On Financial Hardship Exemption
Largo Down More Than 50% In US Premarket As Announces Pricing of Registered Direct Offering and Private Placement, Reliance On Financial Hardship Exemption
Oct 15, 2025
09:14 AM EDT, 10/15/2025 (MT Newswires) -- Largo (LGO.TO and NASDAQ: LGO) was at last look down more than 50% and at 52 week lows levels as its entered Wednesday into securities purchase agreements with institutional and accredited investors for the purchase and sale of 14,262,309 common shares of the company at a purchase price of US$1.22 per common share...
Prologis tops quarterly estimates on strong warehouse leasing
Prologis tops quarterly estimates on strong warehouse leasing
Oct 15, 2025
Oct 15 (Reuters) - Warehouse-focused real estate investment trust Prologis ( PLD ) beat Wall Street estimates for third-quarter revenue and funds from operations on Wednesday, helped by robust demand for its storage facilities. The San Francisco, California-based company also raised its 2025 core FFO forecast to a range of $5.78 per share to $5.81 per share, from $5.75 per...
Scynexis to Receive $22 Million Resolving Disagreement With GSK Over Phase 3 Mario Study; Shares Rise Pre-Bell
Scynexis to Receive $22 Million Resolving Disagreement With GSK Over Phase 3 Mario Study; Shares Rise Pre-Bell
Oct 15, 2025
09:14 AM EDT, 10/15/2025 (MT Newswires) -- Scynexis ( SCYX ) said Wednesday it will receive a $22 million payment from GSK's (GSK) GlaxoSmithKline Intellectual Property (No. 3) Limited, resolving the disagreement related to the restart of the phase 3 Mario study on invasive candidiasis. As per resolution terms, Scynexis ( SCYX ) will terminate the Mario study and receive...
Plumas Bancorp beats Q3 EPS estimates despite income drop
Plumas Bancorp beats Q3 EPS estimates despite income drop
Oct 15, 2025
Overview * Plumas Bancorp ( PLBC ) beats analysts' expectations for Q3 EPS despite decline in net income * Company's Q3 results were influenced by Cornerstone acquisition, which increased assets and deposits * Net interest income rose by $6.3 mln in Q3 2025 Outlook * Company expects cost of funds to decrease slightly following recent changes and Fed rate reduction...
Copyright 2023-2026 - www.financetom.com All Rights Reserved